These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 35680169)
1. The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults. Lee JH; Park K; Lee HS; Park HK; Han JH; Ahn SB Clin Mol Hepatol; 2022 Oct; 28(4):814-826. PubMed ID: 35680169 [TBL] [Abstract][Full Text] [Related]
2. Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. Lee JH; Kwon YJ; Park K; Lee HS; Park HK; Han JH; Ahn SB Nutrients; 2022 Jul; 14(15):. PubMed ID: 35893894 [TBL] [Abstract][Full Text] [Related]
3. Comparison of METS-IR and HOMA-IR for predicting new-onset CKD in middle-aged and older adults. Yoon J; Heo SJ; Lee JH; Kwon YJ; Lee JE Diabetol Metab Syndr; 2023 Nov; 15(1):230. PubMed ID: 37957738 [TBL] [Abstract][Full Text] [Related]
4. Multi-dimensional comparison of abdominal obesity indices and insulin resistance indicators for assessing NAFLD. Shi J; Chen J; Zhang Z; Qian G BMC Public Health; 2024 Aug; 24(1):2161. PubMed ID: 39123158 [TBL] [Abstract][Full Text] [Related]
5. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Son DH; Lee HS; Lee YJ; Lee JH; Han JH Nutr Metab Cardiovasc Dis; 2022 Mar; 32(3):596-604. PubMed ID: 35090800 [TBL] [Abstract][Full Text] [Related]
6. Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study. Motamed N; Miresmail SJ; Rabiee B; Keyvani H; Farahani B; Maadi M; Zamani F J Diabetes Complications; 2016 Mar; 30(2):269-74. PubMed ID: 26718936 [TBL] [Abstract][Full Text] [Related]
7. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance. Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655 [TBL] [Abstract][Full Text] [Related]
8. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes? Gutierrez-Buey G; Núñez-Córdoba JM; Llavero-Valero M; Gargallo J; Salvador J; Escalada J Eur J Intern Med; 2017 Jun; 41():74-78. PubMed ID: 28283346 [TBL] [Abstract][Full Text] [Related]
9. Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults. Lee SB; Kim MK; Kang S; Park K; Kim JH; Baik SJ; Nam JS; Ahn CW; Park JS Endocrinol Metab (Seoul); 2019 Jun; 34(2):179-186. PubMed ID: 31257745 [TBL] [Abstract][Full Text] [Related]
10. Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population. Zeng P; Cai X; Yu X; Gong L Sci Rep; 2023 Nov; 13(1):20470. PubMed ID: 37993481 [TBL] [Abstract][Full Text] [Related]
11. Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study. Cai X; Gao J; Hu J; Wen W; Zhu Q; Wang M; Liu S; Hong J; Wu T; Yang S; Tuerxun G; Li N Dis Markers; 2022; 2022():4930355. PubMed ID: 35251371 [TBL] [Abstract][Full Text] [Related]
13. The Risk for Insulin Resistance according to the Degree of Non-Alcoholic Fatty Liver Disease in Korean Men. Ryoo JH; Hong HP; Park SK; Ham WT; Chung JY J Korean Med Sci; 2016 Nov; 31(11):1761-1767. PubMed ID: 27709854 [TBL] [Abstract][Full Text] [Related]
14. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children. El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627 [TBL] [Abstract][Full Text] [Related]
15. HOMA-IR is an effective biomarker of non-alcoholic fatty liver disease in non-diabetic population. Zeng P; Cai X; Yu X; Huang L; Chen X J Int Med Res; 2023 Oct; 51(10):3000605231204462. PubMed ID: 37862786 [TBL] [Abstract][Full Text] [Related]
16. Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Premenopausal Women with Metabolic Syndrome. El-Sehrawy AA; State O; Elzehery RR; Mohamed AS Horm Metab Res; 2021 Feb; 53(2):100-104. PubMed ID: 33513642 [TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome. Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501 [TBL] [Abstract][Full Text] [Related]
18. The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults. Ju DY; Choe YG; Cho YK; Shin DS; Yoo SH; Yim SH; Lee JY; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI Clin Mol Hepatol; 2013 Jun; 19(2):140-7. PubMed ID: 23837138 [TBL] [Abstract][Full Text] [Related]
19. Harnessing Metabolic Indices as a Predictive Tool for Cardiovascular Disease in a Korean Population without Known Major Cardiovascular Event. Kim HJ; Kim BS; Lee Y; Ahn SB; Kim DW; Shin JH Diabetes Metab J; 2024 May; 48(3):449-462. PubMed ID: 38310879 [TBL] [Abstract][Full Text] [Related]
20. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults. Sinn DH; Gwak GY; Park HN; Kim JE; Min YW; Kim KM; Kim YJ; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC Am J Gastroenterol; 2012 Apr; 107(4):561-7. PubMed ID: 22108448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]